Hepatic Steatosis Inhibits Hepatitis B Virus Replication by Promoting miR ‐122‐5p‐ SOX4
- 20 February 2026
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 33 (3) , e70151
Abstract
The rising prevalence of chronic hepatitis B (CHB) and metabolic dysfunction–associated fatty liver disease (MAFLD) comorbidity necessitates a deeper understanding of their clinical interplay. Although miR‐122 is a known liver‐specific regulator of chronic liver diseases, its specific role in the context of CHB‐MAFLD remains elucidated. In this study, serum analysis revealed that CHB‐MAFLD patients exhibit significantly lower levels of HBV DNA, pgRNA, and HBsAg compared to patients with CHB alone, which correlated with elevated miR‐122 expression. Through bioinformatics and molecular assays, SOX4 was identified as a direct downstream target of miR‐122‐5p. Utilizing an HBV‐infected steatotic cell model, we observed that the comorbid state suppresses HBV replication markers—including DNA, pgRNA, HBsAg, and HBcrAg—while concurrently upregulating the miR‐122‐5p/SOX4 axis. Functional experiments demonstrated that miR‐122‐5p and SOX4 both act as inhibitors of HBV activity, as their knockdown enhanced viral replication, while their overexpression led to significant suppression. These findings suggest that the metabolic environment in CHB‐MAFLD may naturally suppress HBV replication through the activation of a novel miR‐122/SOX4 regulatory axis. This study highlights miR‐122 as a potential therapeutic target and provides a mechanistic basis for the altered viral kinetics observed in patients with dual liver pathology. Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2200063555Keywords
Funding Information
- National Natural Science Foundation of China (82274260)
- Natural Science Foundation of Liaoning Province (2015020305)
This publication has 23 references indexed in Scilit:
- SOX4: The unappreciated oncogeneSeminars in Cancer Biology, 2020
- SOX4: Epigenetic regulation and role in tumorigenesisSeminars in Cancer Biology, 2020
- Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expressionAntiviral Research, 2020
- Total saponins extracted from Abrus cantoniensis Hance suppress hepatitis B virus replication in vitro and in rAAV8-1.3HBV transfected miceJournal of Ethnopharmacology, 2020
- Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral loadJHEP Reports, 2019
- Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approachObesity, 2015
- Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1-modulated P53 activityHepatology, 2011
- microRNAs and cholesterol metabolismTrends in Endocrinology & Metabolism, 2010
- Critical roles for SoxC transcription factors in development and cancerThe International Journal of Biochemistry & Cell Biology, 2010
- miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingCell Metabolism, 2006